This year, Biotech showcased the Onko-SureTM DR 70 ® ELISA Assay and the Cervi-M ® Cervical Cancer Methylation Gene Assay. The Cervi-M ® Cervical Cancer Methylation Gene Test was exhibited for the first time, and the exhibition received enthusiastic responses, and it will become a new generation of cervical cancer screening tools in the future. Onko-SureTM DR 70 ® is a continuous monitoring of fibrin/fibrinogen degradation products in serum to assess treatment effectiveness and the progression of colorectal cancer. Uni Pharma vision is to provide the best choice for medical treatment, marketing and acting as an agent for medical diagnosis, drugs and medical equipment from internationally renowned pharmaceutical companies. At the same time, this exhibition opened the popularity of Uni Pharma, and successfully completed the exhibition.
